Floatz logo

ROSEMARY

Urinary Bladder, Atony Of

University of Oran 1other_biologicalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Urinary Bladder, Atony Of cohort.

Asset / SponsorPhaseRating
Oxybutynin
Astellas Pharma Inc
Phase 4BB
Estriol
Texas Tech University Health Sciences Center
Phase 2/3B
SOLIFENACIN
Astellas Pharma Inc
Phase 4B
Uro Vaxom
Buckinghamshire Healthcare NHS Trust
Phase 2B
LAVENDER OIL
University of Oran 1
N/AD

Same molecule, other indications

ROSEMARY is also rated in:

overactive bladderDormant
D
Indicative ·
30 / 100
View asset →
multiple sclerosisDormant
D
Indicative ·
30 / 100
View asset →
Urinary Incontinence (UI)Dormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →